Drug Profile
Calcipotriol - Mayne pharma
Alternative Names: Calcipotriene - Stiefel; Sorilux; STF 115469; U-0267Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Stiefel Laboratories
- Developer Mayne Pharma; Stiefel Laboratories
- Class Antipsoriatics; Cyclohexanes; Cyclopropanes; Dihydroxycholecalciferols; Indenes; Vitamin D analogues
- Mechanism of Action Calcitriol receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Plaque psoriasis; Psoriasis
Most Recent Events
- 22 May 2019 Registered for Plaque psoriasis (In adolescents) in USA (Topical)
- 28 Feb 2019 No recent reports of development identified for phase-I development in Plaque-psoriasis(In children) in USA (Topical, Foam)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Plaque-psoriasis(In adolescents) in USA (Topical, Foam)